Skip to main content

Table 1 Baseline demographics and clinical characteristics (N = 409)

From: Assessment of efficacy and impact on work productivity and attendance after a mandatory switch to generic second-generation antihistamines: results of a patient survey in Norway

Sex, n (%)

   Female

271 (66.3%)

Age (y), n

   18-25

35

   26-35

67

   36-45

101

   46-55

122

   56-65

84

Diagnosis, %

   Pollen allergy

63.7

   Other nasal allergy

15.2

   Skin allergy/eczema

6.9

   Other

14.3

Pre-switch therapy, %

   Desloratadine

78.4

   Ebastine

16.0

   Fexofenadine

5.6

Post-switch therapy, %

   Cetirizine

64.7

   Loratadine

35.3

Back to article page

Clinical and Molecular Allergy

ISSN: 1476-7961

Contact us